Related references
Note: Only part of the references are listed.New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort
Maria Papp et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Evidence for the involvement of infectious agents in the pathogenesis of Crohns disease
Gert De Hertogh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
IBD serological panels: Facts and perspectives
Lourent Peyrin-Biroulet et al.
INFLAMMATORY BOWEL DISEASES (2007)
New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
Marc Ferrante et al.
GUT (2007)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families:: Implications for genetic testing
Janos Papp et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease
George E. Reese et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease
Iris Dotan et al.
GASTROENTEROLOGY (2006)
Positive and negative predictive values: Use of inflammatory bowel disease serologic markers
GL Austin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Serum immune responses predict rapid disease progression among children with Crohn's disease: Immune responses predict disease progression
MC Dubinsky et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Anti-glycan antibodies as biomarkers for diagnosis and prognosis
N. Dotan et al.
LUPUS (2006)
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease
E Israeli et al.
GUT (2005)
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease
SR Targan et al.
GASTROENTEROLOGY (2005)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease
WS Mow et al.
GASTROENTEROLOGY (2004)
Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease
DG Forcione et al.
GUT (2004)
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype
IDR Arnott et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease?
M Harrer et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease
WJ Sandborn et al.
INFLAMMATORY BOWEL DISEASES (2001)
Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease
S Vermeire et al.
GASTROENTEROLOGY (2001)
Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability:: A study in IBD families
S Vermeire et al.
INFLAMMATORY BOWEL DISEASES (2001)
Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics
EA Vasiliauskas et al.
GUT (2000)
Share Paper
